Akari Therapeutics (AKTX) Shares Repurchased (2023 - 2024)

Akari Therapeutics' (AKTX) quarterly Shares Repurchased came in at $28000.0 in Q4 2024, up 7.69% quarter-over-quarter from $26000.0 in Q3 2024.

Akari Therapeutics (AKTX) Shares Repurchased (2023 - 2024) Analysis & Trends

Akari Therapeutics has disclosed Shares Repurchased across 2 years of filings, most recently posting $28000.0 for Q4 2024.

Shares Repurchased for Q4 2024 came in at $28000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2024 was $28000.0 (changed N/A YoY), and the FY2024 annual result was $28000.0, up 600.0% from the prior year.
Shares Repurchased came in at $28000.0 for Q4 2024 at Akari Therapeutics, up from $26000.0 in the prior quarter.
In the past five years, Shares Repurchased ranged from a high of $28000.0 in Q4 2024 to a low of -$29000.0 in Q2 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Shares Repurchased (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	839,896.00
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	336.90 Mn
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	Regeneron Pharmaceuticals	63.43 Bn	54.67 Bn	3.31 Bn	794.30 Mn

Download Data